Management of COVID patients with convalescent plasma: Do we have the final word?

Immunotherapy with convalescent plasma (CP) has been used in the past in several infectious diseases (influenza, SARS, MERS) with the aim to shorten or stop the phase of viral replication and to improve the patient outcome. However, a clear benefit was never demonstrated.